PHARMA-STATS

Bayesian Methods in Clinical Trials: FDA’s position in 2026

Full Article: 🔗Bayesian Methods in Clinical Trials

#Bayesian model was always a favorite of the professors back in the 1990s. And finally, we see them formally coming on board in modern clinical trials. FDA Commissioner clearly stated “Bayesian methodologies help address two of the biggest problems of drug development: high costs and long timelines”, which is indeed need of today’s time.

Here, shared a basic and practical version of “Bayesian Methods in Clinical Trials: Basic Understanding” – designed for anyone who wants to understand the concept without heavy maths.

Thank you to the #FDA team for the explicit clarification that ‘NO’ specific ‘statistical #software‘ is required for Bayesian statistical analyses. This clarity rightly emphasizes that methodological rigor, transparency, and reproducibility including the use of #opensource tools define credible research.

🔗 Read directly FDA Draft Guidance (January 2026): https://lnkd.in/gpWXVz6M